Wednesday, May 31, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

What Will the CBRNE Defense Act of 2015 Cost?

by Global Biodefense Staff
December 1, 2015

The Congressional Budget Office today published a cost estimate for H.R. 3875, which would establish the Chemical, Biological, Radiological, Nuclear, and Explosives Office in the Department of Homeland Security (DHS), consisting of existing offices in DHS.

The legislation also would require the Government Accountability Office (GAO), within two years of the bill’s enactment, to prepare a report to the Congress on DHS research and development programs relating to explosives and chemical, biological, radiological, and nuclear threats.

H.R. 3875 was introduced on Nov. 2, 2015 by Rep. McCaul, Michael T. (R-TX). The mission of the CBRNE Office is to coordinate, strengthen, and provide chemical, biological, radiological, nuclear, and explosives (CBRNE) capabilities in support of homeland security.

The CBRNE Office will be headed by an Assistant Secretary for the Chemical, Biological, Radiological, Nuclear, and Explosives Office, who shall be appointed by the President and approved by the Senate.

Responsibilities of the Assistant Secretary shall include:

  • Develop, coordinate, and maintain overall CBRNE strategy and policy for DHS
  • Develop, coordinate, and maintain for the DHS periodic CBRNE risk assessments
  • Serve as the primary Department representative for coordinating CBRNE activities with other Federal departments and agencies
  • Provide oversight for DHS preparedness for CBRNE threats
  • Provide support for operations during CBRNE threats or incidents

The Director of the Chemical Division, the Director of the Biological Division, the Director of the Nuclear Division, and the Director of the Explosives Division shall report directly to the Assistant Secretary.

The functions, personnel, budget authority, and assets of the following offices would be transferred to the CBRNE Office:

  • The Office of Health Affairs, including the Chief Medical Officer and the National Biosurveillance Integration Center
  • The Domestic Nuclear Detection Office (and redesignated as the Nuclear Division)
  • CBRNE threat awareness and risk assessment activities of the Science and Technology Directorate.
  • The CBRNE functions of the Office of Policy and the Office of Operations Coordination.
  • The Office for Bombing Prevention of the National Protection and Programs Directorate

Based on information from the department on its current plans to consolidate the offices affected by the bill, CBO estimates that implementing H.R. 3875 would not significantly affect DHS spending. Based on the cost of similar reports, they estimate that it would cost GAO less than $1 million over the 2016-2017 period to prepare the report required by the bill.

CBO estimates that enacting H.R. 3875 would not increase net direct spending or on-budget deficits in any of the four consecutive 10-year periods beginning in 2026.

Tags: Chemical Detection

Related Posts

Vials of finished vaccines
Funding News

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Load More

Latest News

Vials of finished vaccines

UK Biomanufacturing Fund to Bolster Supply Chain Resilience and Pandemic Preparedness

May 26, 2023
Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

Dr. Sen Pei Discusses Challenges in Forecasting Antimicrobial Resistance

April 26, 2023
Biodefense Headlines – 25 April 2023

Biodefense Headlines – 25 April 2023

April 25, 2023
Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

Aptitude Awarded Up to $54M BARDA Funding for At-Home Diagnostics

April 20, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2023 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2023 Stemar Media Group LLC